Vimarsana
Biggest News Aggregation in the World

Randomized Controlled Trial Emulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Controlled Trial Emulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Controlled Trial Emulation Today - Breaking & Trending Today

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials - Vimarsana News

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

/PRNewswire/ -- Aetion®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce the culmination of the RCT-DUPLICATE...

RCT-DUPLICATE findings demonstrate capabilit - Vimarsana News

RCT-DUPLICATE findings demonstrate capabilit

NEW YORK, April 25, 2023 ‒ Aetion®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce the culmination of the RCT-DUPLICATE demonstration project, with complete findings published today in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD) — data from patients’ day-to-day interactions with the healthcare system — would obtain similar results to findings from randomized clinical trials (RCTs). In cases where clinical trial designs al...

Aetion, FDA to Evaluate Real-World Data Standardization for COVID-19 - Vimarsana News

Aetion, FDA to Evaluate Real-World Data Standardization for COVID-19

FDA has extended Aetion’s contract to evaluate real-world data (RWD) involving COVID-19 medical countermeasures

Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence - Vimarsana News

Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence

/PRNewswire/ -- Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced the launch of the Coalition for the...

Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence - Vimarsana News

Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence

The Aetion CARE Initiative aims to become the standard bearer for best practices and efficiencies in RWE development and decision making